GNC comparable store sales jump 16% in 2nd quarter; P&G, Menley report results.
This article was originally published in The Tan Sheet
Executive Summary
GNC COMPARABLE-STORE SALES GREW 16.2% IN THE SECOND QUARTER while franchise comparable-store sales increased 19.3% during the three-month period ended July 22, the dietary supplement retailer announced Aug. 8. General Nutrition Companies reported that the comparable-store performance was "driven primarily by the continued demand for all supplement categories (vitamins, herbs and sports nutrition products) and further expansion of the company's Gold Card program" -- a membership program that entitles enrollees to once-a-month discounts
You may also be interested in...
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.
Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups
Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.
Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.